Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Endothelin-1 on the Development of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: Endothelin Receptor Antagonism and Vasomotor Function

NCT05373108 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05373108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05373108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Endothelin-1 on the Development of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: Endothelin Receptor Antagonism and Vasomotor Function
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
May 19, 2022
Completion date
February 14, 2023
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac allograft vasculopathy